Biotechnology News

May 31, 2012

NORWALK, Conn.--(BUSINESS WIRE)--The Multiple Myeloma Research Consortium (MMRC) today announced four data presentations from multiple myeloma studies conducted through its clinical trial sites, in collaboration with industry partners, Bristol-...

May 31, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com, a medical device company focused on the diagnosis and treatment of the neurological...

May 31, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: During May, 48,374 new B shares were issued in Elekta (STO:EKTAB) through the exercise of employee options distributed within the framework of the established employee option program. The total number...

May 31, 2012

PITTSBURGH--(BUSINESS WIRE)--Precision Therapeutics releases data on the clinical utility of ChemoFx in treatment selection for Cervical Cancer patients

May 31, 2012

FARMINGTON, Conn.--(BUSINESS WIRE)--See the conclusion to Medtronic's TKA webinar series.

May 31, 2012

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE: MDT), the world’s leading medical technology company, today announced it will participate in the Goldman Sachs 33rd Annual Global Healthcare Conference on Tuesday, June 5, 2012, in Long Beach,...

May 31, 2012

WASHINGTON--(BUSINESS WIRE)--America’s biopharmaceutical research companies are testing 981 medicines and vaccines to fight cancer, according to a report released today by the Pharmaceutical Research and Manufacturers of America.

May 31, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Results from Cutting Edge Information's report "Pharmaceutical Business Development and Licensing," reveal the most common conflicts that damage drug development and commercialization partnerships....

May 31, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed U.S. rheumatologists and managed care organization (MCO) pharmacy...

May 31, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles issues the first of three white papers on the expanding role of modeling and simulation across the drug development lifecycle.

May 31, 2012

MADISON, Wis.--(BUSINESS WIRE)--Promega announces the launch of a novel luciferase that is smaller, brighter, and more versatile than any current bioluminescent enzyme.

May 31, 2012

MINNEAPOLIS--(BUSINESS WIRE)--Memorial Medical Center of West Michigan Selects ProVation Order Sets as its electronic order set solution.

May 31, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Cutting Edge Information will host the webinar “Five Key Trends to Support MSL Planning Strategies” and present results from recent research on strategic forces driving the evolution of MSL teams

May 31, 2012

PORT WASHINGTON, N.Y.--(BUSINESS WIRE)----- ForteBio®, a division of Pall Life Sciences announced the introduction of its Dip and Read™ Ni-NTA biosensor for use on its Octet® and BLItz™ instrumentation platforms.

May 31, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--N-of-One, Inc. announced today the appointment of Christine Cournoyer as the company’s Chief Executive Officer.

May 31, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--N-of-On, Inc. announced a unique knowledge integration platform, PrecisionWorks, to enable care providers and patients to make informed decisions about diagnostic and treatment strategy.

May 31, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--N-of-One, Inc. announced today that the company has entered into a strategic collaboration with Foundation Medicine, Inc.to support the development of its fully informative molecular cancer profiles.

May 31, 2012

SAN DIEGO--(BUSINESS WIRE)--Silicon Biosystems, Inc., a provider of specialized molecular and cellular biology technology, has opened laboratory facilities in San Diego on the La Jolla Torrey Pines mesa.

May 31, 2012

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) announced today that management will present at the following upcoming investor conferences. The presentations will be webcast live and available for replay from Seattle...

May 31, 2012

NEEDHAM, Mass.--(BUSINESS WIRE)--Celldex Therapeutics, Inc. (Nasdaq: CLDX) today announced that Anthony S. Marucci, President and Chief Executive Officer of Celldex Therapeutics, Inc., will present at the Jefferies 2012 Global Healthcare...

May 31, 2012

BOSTON--(BUSINESS WIRE)--OvaScience™, a fertility company focused on the discovery, development and commercialization of new treatments for infertility, announced today that Michelle Dipp, M.D., Ph.D., chief executive officer of OvaScience, will...

May 31, 2012

WOBURN, Mass.--(BUSINESS WIRE)--ArQule announces upcoming presentation at Jefferies 2012 Global Healthcare Conference.

May 31, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Catabasis Pharmaceuticals, a clinical stage biopharmaceutical company dedicated to the discovery and development of innovative, effective and safe medicines for the treatment of inflammatory and metabolic...

May 31, 2012

SAN ANTONIO--(BUSINESS WIRE)--GenSpera appoints new Board member.

May 31, 2012

REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma, Inc. today announced that an abstract analyzing a subset of efficacy results from its Phase 3 trial of APF530 has been published in conjunction with the ASCO Annual Meeting.

May 31, 2012

RESTON, Va.--(BUSINESS WIRE)--Govplace, a leading Solution Provider for the public sector, announced today that it is on a winning team of the CIO-SP 3 Government-Wide Acquisition Contract (GWAC). The contract was awarded to Hygeia Solutions...

May 31, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem will present at Jefferies 2012 Global Healthcare Conference on June 7, 2012, at 9am ET.

May 31, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio, a world leader in the development of innovative gene therapies for severe genetic disorders, today announced that John Maraganore, Ph.D., has joined the company’s board of directors. Dr. Maraganore...

May 31, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix and Lecia collaborate to automate and reduce assay time for RNA in situ hybridization (ISH) tissue analysis to speed drug discovery and translational research applications.

May 31, 2012

WORCESTER, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation (OTCBB: RXII.OB) today announced that it has received clearance for its investigational new drug application (IND) from the U.S. Food and Drug Administration (FDA) to initiate...

May 31, 2012

ZURICH-SCHLIEREN, Switzerland--(BUSINESS WIRE)--Molecular Partners AG, the leader in the discovery and development of DARPins®, a novel class of therapeutic proteins, today announced the appointment of Lisa Rojkjaer, MD as Chief Medical Officer,...

May 31, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum announces key ZEVALIN- and belinostat-related abstracts at ASCO annual meeting.

May 31, 2012

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the Jefferies 2012 Global Healthcare Conference on Tuesday, June 5, 2012, at 10:00 a.m. EDT (3:00 p.m. BST) in New York...

May 31, 2012

MANSFIELD, Mass.--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, will present at the Goldman Sachs 33rd Global Healthcare Conference in Rancho Palos Verdes, CA, on Thursday, June 7, 2012. José E. Almeida...

May 31, 2012

EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NYSE Amex: AIS) today announced that Paul K. Wotton, Ph.D., President and Chief Executive Officer, will present at the 2012 Jefferies Global Healthcare Conference on Thursday June 7, 2012 at 3:...

May 31, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina (NASDAQ:ILMN) today introduced the Nextera XT DNA Sample Preparation Kit, the easiest way for researchers to prepare and sequence small genomes, PCR amplicons, and plasmids. When paired with Illumina’s MiSeq...

May 31, 2012

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) will present research at the 4th Collaborative Meeting of the Consortium of Multiple Sclerosis Centers (CMSC) and Americas Committee for Treatment and Research in Multiple...

May 31, 2012

CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--Tau Therapeutics has initiated a Phase Ib clinical trial with the NCI’s Adult Brain Tumor Consortium using the T-type calcium channel inhibitor mibefradil in patients with recurrent high-grade glioma.

May 31, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC Anticipates Favorable Test Results of New Brain Injury Treatment

May 31, 2012

MORRIS PLAINS, N.J.--(BUSINESS WIRE)--Temptime Corporation, the world leader in time temperature indicators, announced the opening of a business office in Beijing, China, marking a significant advancement in their global effort to improve...

May 31, 2012

TOKYO--(BUSINESS WIRE)--R-Tech Ueno (JASDAQ:4573) has announced that it has been notified by the International Court of Arbitration, International Chamber of Commerce (ICC), that the anticipated date of the arbitration decision has been extended...

May 31, 2012

SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News: Aerocrine (STO:AEROB): With reference to Chapter 4 Section 9 in ”lagen (1991:980) om handel med finansiella instrument” it’s hereby announced that through the completion of a new share issue,...

May 31, 2012

SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Regulatory News: MEDIAN Technologies (Paris:ALMDT), a leading medical imaging software developer and service provider for oncology clinical trials, announced today its participation in the 2012 ASCO...

May 31, 2012

BAGNEAUX, France--(BUSINESS WIRE)--Regulatory News: DBV Technologies (Paris:DBV) (Euronext: DBV – ISIN: FR0010417345), creator of Viaskin®, a new standard in the treatment of allergy, announced today the appointment of Pr. Hugh Sampson to its...

May 30, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today announced that the Company will present at the Goldman Sachs Global Healthcare...

May 30, 2012

MINNEAPOLIS--(BUSINESS WIRE)--Minnesota Lt. Governor and Commissioners Visit Biobased Chemicals Industry Leaders.

May 30, 2012

TORONTO--(BUSINESS WIRE)--SQI Reports Second Quarter Results

May 30, 2012

TORONTO--(BUSINESS WIRE)--Medworxx announces highest quarter of revenues achieved since the company’s inception.